BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 27691399)

  • 1. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
    Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
    J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Specific Encoding of Photoactivity in Antibodies Enables Light-Mediated Antibody-Antigen Binding on Live Cells.
    Bridge T; Shaikh SA; Thomas P; Botta J; McCormick PJ; Sachdeva A
    Angew Chem Int Ed Engl; 2019 Dec; 58(50):17986-17993. PubMed ID: 31609054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structural characterization of a Zn
    Kumar S; Mahendran I; Athreya A; Ranjan R; Penmatsa A
    J Biol Chem; 2020 Jan; 295(1):55-68. PubMed ID: 31699895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic analysis of an entropically driven, high-affinity nanobody-HIV p24 interaction.
    Brookes JC; Gray ER; Loynachan CN; Gut MJ; Miller BS; P S Brogan A; McKendry RA
    Biophys J; 2023 Jan; 122(2):279-289. PubMed ID: 36527237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photobodies: Light-Activatable Single-Domain Antibody Fragments.
    Jedlitzke B; Yilmaz Z; Dörner W; Mootz HD
    Angew Chem Int Ed Engl; 2020 Jan; 59(4):1506-1510. PubMed ID: 31755215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of two nanobodies targeting the ligand-binding pocket of human Arc.
    Godoy Muñoz JM; Neset L; Markússon S; Weber S; Krokengen OC; Sutinen A; Christakou E; Lopez AJ; Bramham CR; Kursula P
    PLoS One; 2024; 19(4):e0300453. PubMed ID: 38683783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering an EGFR-binding Gp2 domain for increased hydrophilicity.
    Du F; Kruziki MA; Zudock EJ; Zhang Y; Lown PS; Hackel BJ
    Biotechnol Bioeng; 2019 Mar; 116(3):526-535. PubMed ID: 30536855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies.
    Hong H; Zhou Z; Zhou K; Liu S; Guo Z; Wu Z
    Chem Sci; 2019 Oct; 10(40):9331-9338. PubMed ID: 32110296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Assessment of Energetic Contributions of Residues in a SARS-CoV-2 Viral Enzyme/Nanobody Interface.
    Kumar A; Vashisth H
    J Chem Inf Model; 2024 Mar; 64(6):2068-2076. PubMed ID: 38460144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of cold- and warm-adapted Endonucleases A using sequence analyses and molecular dynamics simulations.
    Michetti D; Brandsdal BO; Bon D; Isaksen GV; Tiberti M; Papaleo E
    PLoS One; 2017; 12(2):e0169586. PubMed ID: 28192428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Evolution of Antiparathion Nanobody with Enhanced Sensitivity and Specificity Based on Structural Analysis.
    Li JD; Shen X; Xu ZL; Liang YF; Shen YD; Yang JY; Wang H
    J Agric Food Chem; 2023 Oct; 71(40):14758-14768. PubMed ID: 37768036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors.
    Renard E; Collado Camps E; Canovas C; Kip A; Gotthardt M; Rijpkema M; Denat F; Goncalves V; van Lith SAM
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery.
    Ando Y; Nakazawa H; Miura D; Otake M; Umetsu M
    Sci Rep; 2021 Nov; 11(1):21882. PubMed ID: 34750461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational Entropy as a Potential Liability of Computationally Designed Antibodies.
    Löhr T; Sormanni P; Vendruscolo M
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectral analysis of molecular dynamics simulations on PDZ: MD sectors.
    Lakhani B; Thayer KM; Black E; Beveridge DL
    J Biomol Struct Dyn; 2020 Feb; 38(3):781-790. PubMed ID: 31262238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient
    Öhlknecht C; Katz S; Kröß C; Sprenger B; Engele P; Schneider R; Oostenbrink C
    J Chem Inf Model; 2021 Mar; 61(3):1193-1203. PubMed ID: 33570387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel force assay for protein-protein interactions.
    Aschenbrenner D; Pippig DA; Klamecka K; Limmer K; Leonhardt H; Gaub HE
    PLoS One; 2014; 9(12):e115049. PubMed ID: 25546146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Activity Maturation of a Single-Domain Antibody with Non-canonical Amino Acids through Chemical Mutagenesis.
    Lindstedt PR; Aprile FA; Sormanni P; Rakoto R; Dobson CM; Bernardes GJL; Vendruscolo M
    Cell Chem Biol; 2021 Jan; 28(1):70-77.e5. PubMed ID: 33217338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the type III interferon complex and its applications in protein engineering.
    Grubbe WS; Byléhn F; Alvarado W; de Pablo JJ; Mendoza JL
    Biophys J; 2023 Nov; 122(21):4254-4263. PubMed ID: 37794680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Barrier Hydrogen Bond Determines Target-Binding Affinity and Specificity of the Antitubercular Drug Bedaquiline.
    Słabońska J; Sappati S; Marciniak A; Czub J
    ACS Med Chem Lett; 2024 Feb; 15(2):265-269. PubMed ID: 38352844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.